TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32588049

Group type: EXPERIMENTAL
Intervention: Higher waist-hip ratio (WHR)
Number of subjects: 451097

Group type: EXPERIMENTAL
Intervention: Higher WHR adjusted for BMI
Number of subjects: 451097

Group type: EXPERIMENTAL
Intervention: Higher body mass index (BMI)
Number of subjects: 451097

Group type: EXPERIMENTAL
Intervention: Higher body-fat percentage
Number of subjects: 451097

Group type: EXPERIMENTAL
Intervention: Coffee consumption
Number of subjects: 451097

Group type: EXPERIMENTAL
Intervention: Smoking status and frequency
Number of subjects: 451097
Study: 35938276

Group type: EXPERIMENTAL
Intervention: APMaT (workplace alcohol prevention program)
Number of subjects: 187

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 187
Study: 33197270

Group type: EXPERIMENTAL
Intervention: 5% ibuprofen gel
Number of subjects: 22

Group type: EXPERIMENTAL
Intervention: 0.025% capsaicin cream
Number of subjects: 22

Group type: COMPARATOR
Intervention: Comparison of ibuprofen and capsaicin
Number of subjects: 22
Study: 34013569

Group type: EXPERIMENTAL
Intervention: Registered RCTs (66/155, 42.6%)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Each additional year of publication
Number of subjects: 155
Study: 32635181

Group type: EXPERIMENTAL
Intervention: Vitamin B‐6 (50 mg pyridoxine/d)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: GSH (500 mg/d)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: B‐6 + GSH
Number of subjects: 61

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: High levels of GSH, high GSH/oxidized GSH ratio, and high GSH-St activity at baseline
Number of subjects: 61
Study: 35971130

Group type: EXPERIMENTAL
Intervention: Everyday Life Rehabilitation (ELR) plus treatment as usual (TAU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Everyday Life Rehabilitation (ELR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Treatment as usual (TAU)
Number of subjects: 0
Study: 33551217

Group type: EXPERIMENTAL
Intervention: High fructose diet (HiFruD, 1.4 g kg−1 day−1 fructose + 0.1 g kg−1 day−1 glucose)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High fructose diet (HiFruD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Low fructose diet (LoFruD, <10 g/d)
Number of subjects: 12
Study: 32767824

Group type: EXPERIMENTAL
Intervention: t‐VNS
Number of subjects: 33

Group type: COMPARATOR
Intervention: sham
Number of subjects: 33
Study: 35574968

Group type: EXPERIMENTAL
Intervention: High intensity interval training (HIIT) for 6 months
Number of subjects: 60

Group type: COMPARATOR
Intervention: Usual care (control group) for 6 months
Number of subjects: 60
Study: 33639906

Group type: EXPERIMENTAL
Intervention: Blended learning
Number of subjects: 37

Group type: COMPARATOR
Intervention: E-learning
Number of subjects: 37

Group type: COMPARATOR
Intervention: Lecture group
Number of subjects: 37

Group type: COMPARATOR
Intervention: All groups (Blended, E-learning, Lecture)
Number of subjects: 37
Study: 34171880

Group type: EXPERIMENTAL
Intervention: Bupivacaine (0.5% without epinephrine)
Number of subjects: 130

Group type: COMPARATOR
Intervention: Normal saline (control)
Number of subjects: 130
Study: 32803824

Group type: EXPERIMENTAL
Intervention: Alcohol beverage
Number of subjects: 158

Group type: COMPARATOR
Intervention: Placebo beverage
Number of subjects: 158

Group type: COMPARATOR
Intervention: Control beverage
Number of subjects: 158
Study: 34268773

Group type: EXPERIMENTAL
Intervention: suppression
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: acceptance
Number of subjects: 80

Group type: COMPARATOR
Intervention: control
Number of subjects: 80
Study: 33685411

Group type: EXPERIMENTAL
Intervention: Prevenar13™ (P) at 2–4‐6 months (_PPP)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Synflorix™ (S) at 2–4‐6 months (_SSS)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Synflorix™ at 1–2‐4 months plus Prevenar13™ at 6 months (SSSP)
Number of subjects: 425

Group type: EXPERIMENTAL
Intervention: Combined group (all interventions)
Number of subjects: 425

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 425
Study: 32950036

Group type: EXPERIMENTAL
Intervention: Circumferential phototherapy unit
Number of subjects: 42

Group type: COMPARATOR
Intervention: Ordinary phototherapy unit
Number of subjects: 42
Study: 34564755

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE) during Follicular Phase (FP)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE) during Luteal Phase (LP)
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE) during both phases
Number of subjects: 14
Study: 32555695

Group type: COMPARATOR
Intervention: Tadalafil (placebo arm of a phase 3 trial)
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Prognostic score adjustment in randomized trials
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Combining measures of ambulatory function
Number of subjects: 371

Group type: EXPERIMENTAL
Intervention: Randomized clinical trials with validated prognostic score
Number of subjects: 371
Study: 33185824

Group type: EXPERIMENTAL
Intervention: Harm Reduction Treatment for Alcohol (HaRT‐A)
Number of subjects: 168

Group type: COMPARATOR
Intervention: Services as usual
Number of subjects: 168
Study: 36343988

Group type: EXPERIMENTAL
Intervention: Insoles adapted in flip-flop sandals
Number of subjects: 80

Group type: COMPARATOR
Intervention: Flip-flop sandals with sham (flat) insoles
Number of subjects: 80
Study: 34461931

Group type: EXPERIMENTAL
Intervention: Cost-offset CSA plus tailored nutrition education
Number of subjects: 305

Group type: COMPARATOR
Intervention: Control (delayed intervention)
Number of subjects: 305
Study: 33576828

Group type: EXPERIMENTAL
Intervention: Nonverbal communication strategies and social cues used by pediatricians during mask-wearing encounters.
Number of subjects: 0
Study: 32184026

Group type: EXPERIMENTAL
Intervention: Standard dose of ready-to-use therapeutic food (RUTF)
Number of subjects: 452

Group type: EXPERIMENTAL
Intervention: Reduced dose of ready-to-use therapeutic food (RUTF)
Number of subjects: 452

Group type: COMPARATOR
Intervention: Community controls
Number of subjects: 452
Study: 35896378

Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg once daily for 2 weeks
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Doxycycline 200 mg once daily for 6 weeks
Number of subjects: 121

Group type: COMPARATOR
Intervention: Placebo for 4 weeks after 2 weeks of doxycycline
Number of subjects: 121
Study: 33427382

Group type: EXPERIMENTAL
Intervention: Communication skill training (CST) for APNs, 6 hours under guidance of facilitators and simulated patients
Number of subjects: 61

Group type: COMPARATOR
Intervention: Control group (no CST)
Number of subjects: 61

Group type: EXPERIMENTAL
Intervention: Communication skill training (CST) for APNs
Number of subjects: 61
Study: 32727748

Group type: EXPERIMENTAL
Intervention: High inferior mesenteric artery ligation (Group 1)
Number of subjects: 46

Group type: COMPARATOR
Intervention: Low inferior mesenteric artery ligation (Group 2)
Number of subjects: 46
Study: 34998255

Group type: EXPERIMENTAL
Intervention: TEACH intervention (IT-enabled nurse care manager, opioid education, academic detailing, access to addiction specialists)
Number of subjects: 114

Group type: EXPERIMENTAL
Intervention: TEACH intervention
Number of subjects: 114

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 114
Study: 33787041

Group type: EXPERIMENTAL
Intervention: Enteral nutrition (EN) combined with aminophylline and beclomethasone
Number of subjects: 115

Group type: COMPARATOR
Intervention: Aminophylline and beclomethasone (Control group)
Number of subjects: 115
Study: 32301996

Group type: EXPERIMENTAL
Intervention: DM1-NFP
Number of subjects: 0

Group type: COMPARATOR
Intervention: DM1
Number of subjects: 0

Group type: COMPARATOR
Intervention: Untreated controls
Number of subjects: 0
Study: 2012267329

Group type: EXPERIMENTAL
Intervention: ALEXIS wound retractor (n=34)
Number of subjects: 72

Group type: COMPARATOR
Intervention: Conventional wound protection (n=34)
Number of subjects: 72
Study: 33658293

Group type: EXPERIMENTAL
Intervention: Single dose of intramuscular respiratory syncytial virus (RSV) F‐protein vaccine
Number of subjects: 4636

Group type: COMPARATOR
Intervention: Placebo vaccine
Number of subjects: 4636
Study: 33179071

Group type: EXPERIMENTAL
Intervention: Infliximab
Number of subjects: 258

Group type: COMPARATOR
Intervention: SSZ and HCQ
Number of subjects: 258
Study: 32113309

Group type: EXPERIMENTAL
Intervention: Acoustic quantification of oral diadochokinetic (DDK) task using [ka] sequences
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Acoustic quantification of oral diadochokinetic (DDK) task using [pa] sequences
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Acoustic quantification of oral diadochokinetic (DDK) task using [ta] sequences
Number of subjects: 68

Group type: EXPERIMENTAL
Intervention: Ordinal regression models trained on 80% of ratings and acoustic DDK predictors
Number of subjects: 68
Study: 35322608

Group type: EXPERIMENTAL
Intervention: Double button plate combined with strengthened anchor technique
Number of subjects: 42

Group type: COMPARATOR
Intervention: Clavicular hook plate internal fixation
Number of subjects: 42
Study: 33152142

Group type: EXPERIMENTAL
Intervention: Intravesical BCG treatment
Number of subjects: 96
Study: 35333639

Group type: EXPERIMENTAL
Intervention: HEART-P intervention (Healthy Emotions and Relationships with Teens-A Guide for Parents); 10-week open trial.
Number of subjects: 15
Study: 34338069

Group type: EXPERIMENTAL
Intervention: Surgical left atrial appendage occlusion
Number of subjects: 4811

Group type: COMPARATOR
Intervention: No occlusion
Number of subjects: 4811
Study: 32470975

Group type: EXPERIMENTAL
Intervention: Vitamin B-12 supplementation (50 μg daily orally)
Number of subjects: 132

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 132

Group type: EXPERIMENTAL
Intervention: Combined intervention and placebo groups for secondary analyses
Number of subjects: 132
Study: 34469628

Group type: EXPERIMENTAL
Intervention: Medicines Management Optimisation Review (MOR)
Number of subjects: 200

Group type: COMPARATOR
Intervention: Standard pharmaceutical care
Number of subjects: 200
Study: 32988598

Group type: EXPERIMENTAL
Intervention: Vitamin D therapy (approximately 1,200 IU daily)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group not specified
Number of subjects: 48
Study: 35857130

Group type: EXPERIMENTAL
Intervention: 0.125 mg xanthohumol
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 14
Study: 33504245

Group type: EXPERIMENTAL
Intervention: Mindfulness group (n = 30)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Wait-list control group (n = 30)
Number of subjects: 60
Study: 35435296

Group type: EXPERIMENTAL
Intervention: Trimax-360 Serum applied twice a day for 98 days
Number of subjects: 30
Study: 32971774

Group type: EXPERIMENTAL
Intervention: Low Glycemic Index (LGI) carbohydrate supplementation
Number of subjects: 14

Group type: EXPERIMENTAL
Intervention: High Glycemic Index (HGI) carbohydrate supplementation
Number of subjects: 14

Group type: COMPARATOR
Intervention: Placebo (PLA) supplementation
Number of subjects: 14
Study: 35395946

Group type: EXPERIMENTAL
Intervention: TEAS + PPI
Number of subjects: 70

Group type: COMPARATOR
Intervention: PPI
Number of subjects: 70
Study: 33923923

Group type: EXPERIMENTAL
Intervention: Nutritional intake assessment using EPIC questionnaire and 24-h dietary recall
Number of subjects: 157

Group type: EXPERIMENTAL
Intervention: Predictive model using ridge regression
Number of subjects: 157
Study: 32514751

Group type: EXPERIMENTAL
Intervention: CBD 10 mg/kg/day plus current clinical management (CCM)
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: CBD 20 mg/kg/day plus CCM
Number of subjects: 4

Group type: EXPERIMENTAL
Intervention: CBD with clobazam
Number of subjects: 4

Group type: COMPARATOR
Intervention: CCM plus placebo
Number of subjects: 4
Study: 34854417

Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Nitroglycerin
Number of subjects: 128

Group type: EXPERIMENTAL
Intervention: Granisetron
Number of subjects: 128

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 128
Study: 32048205

Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study: 34419431

Group type: EXPERIMENTAL
Intervention: Modified puromycin derivatives with altered amino acids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Misacylated tRNAs containing altered amino acids
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Dipeptides and dipeptidomimetics
Number of subjects: 0
Study: 32513564

Group type: EXPERIMENTAL
Intervention: SC-003 at 0.3 mg/kg and 0.2 mg/kg
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: SC-003 monotherapy or in combination with budigalimab
Number of subjects: 74

Group type: EXPERIMENTAL
Intervention: SC-003
Number of subjects: 74
Study: 34699852

Group type: EXPERIMENTAL
Intervention: Depressive symptoms
Number of subjects: 406
Study: 34043117

Group type: EXPERIMENTAL
Intervention: Trehalose-HA eye drops
Number of subjects: 60

Group type: COMPARATOR
Intervention: 0.1% Hyaluronic Acid (HA)
Number of subjects: 60
Study: 32043302

Group type: EXPERIMENTAL
Intervention: Omiganan (OMN) + Imiquimod (IMQ)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Imiquimod (IMQ)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Omiganan (OMN)
Number of subjects: 16
Study: 36255239

Group type: EXPERIMENTAL
Intervention: 2.4 g CAS+IMD
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: 8.0 g CAS+IMD
Number of subjects: 178

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 178

Group type: EXPERIMENTAL
Intervention: CAS+IMD combined-dose
Number of subjects: 178
Study: 33549862

Group type: EXPERIMENTAL
Intervention: Sour stimulus
Number of subjects: 52

Group type: EXPERIMENTAL
Intervention: Sour-cold stimulus
Number of subjects: 52

Group type: COMPARATOR
Intervention: Natural stimulus
Number of subjects: 52

Group type: COMPARATOR
Intervention: Cold stimulus
Number of subjects: 52
Study: 34352828

Group type: EXPERIMENTAL
Intervention: Economic vulnerability during pregnancy (defined as household income <200% of federal poverty level, part-time or no employment, use of government insurance)
Number of subjects: 955

Group type: EXPERIMENTAL
Intervention: Economic vulnerability during pregnancy (restricted to household income <100% of federal poverty level)
Number of subjects: 955
Study: 33078615

Group type: EXPERIMENTAL
Intervention: Water, sanitation, and hygiene interventions (WASH Benefits)
Number of subjects: 0
Study: 34334677

Group type: EXPERIMENTAL
Intervention: Vibration
Number of subjects: 56

Group type: COMPARATOR
Intervention: Control
Number of subjects: 56
Study: 34121357

Group type: EXPERIMENTAL
Intervention: Acetaminophen syrup (320 mg/10 ml)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Ibuprofen syrup (200 mg/10 ml)
Number of subjects: 66

Group type: COMPARATOR
Intervention: Placebo solution
Number of subjects: 66
Study: 36245883

Group type: EXPERIMENTAL
Intervention: Repetitive transcranial magnetic stimulation (rTMS) applied over the right dorsolateral prefrontal cortex (DLPFC) for 20 sessions within four consecutive weeks.
Number of subjects: 30

Group type: COMPARATOR
Intervention: Sham rTMS applied over the right dorsolateral prefrontal cortex (DLPFC) for 20 sessions within four consecutive weeks.
Number of subjects: 30
Study: 32079623

Group type: EXPERIMENTAL
Intervention: Avelumab (10 mg/kg, 2 weekly for 24 weeks)
Number of subjects: 402

Group type: COMPARATOR
Intervention: Standard fluoropyrimidine‐based chemotherapy (capecitabine, oxaliplatin for 12 weeks or capecitabine for 24 weeks)
Number of subjects: 402
Study: 35022885

Group type: EXPERIMENTAL
Intervention: Guided art observation
Number of subjects: 73

Group type: EXPERIMENTAL
Intervention: Art observation without guided discussion
Number of subjects: 73

Group type: COMPARATOR
Intervention: Control group (no art observation)
Number of subjects: 73
Study: 33507773

Group type: EXPERIMENTAL
Intervention: Introducing a slightly worse version of an existing suicide prevention resource (decoy)
Number of subjects: 0
Study: 33626889

Group type: EXPERIMENTAL
Intervention: Remote hemodynamic-guided pharmacotherapy (treatment)
Number of subjects: 190

Group type: COMPARATOR
Intervention: Usual HF care (control)
Number of subjects: 190
Study: 34854317

Group type: EXPERIMENTAL
Intervention: Chest compression only (CCO)‐CPR at 200 m altitude
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chest compression only (CCO)‐CPR at 3000 m altitude
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Chest compression only (CCO)‐CPR at 5000 m altitude
Number of subjects: 48
Study: 616837598

Group type: EXPERIMENTAL
Intervention: intermittent TBS (iTBS600)
Number of subjects: 10

Group type: EXPERIMENTAL
Intervention: continuous TBS (cTBS600)
Number of subjects: 10

Group type: COMPARATOR
Intervention: sham stimulation
Number of subjects: 10
Study: 35296293

Group type: EXPERIMENTAL
Intervention: Non-surgical spinal decompression therapy (NSD) in addition to routine physical therapy
Number of subjects: 60
Study: 33847683

Group type: EXPERIMENTAL
Intervention: Nicorandil
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Alprostadil
Number of subjects: 90

Group type: COMPARATOR
Intervention: Nitroglycerin
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 90
Study: 35799556

Group type: EXPERIMENTAL
Intervention: Gabapentin (800 mg)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Clonidine (300 mcg)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 75
Study: 32716652

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT)
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Pelvic floor muscle training (PFMT) + game therapy (GT)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Both treatments (PFMT and PFMT+GT)
Number of subjects: 32
Study: 32334045

Group type: EXPERIMENTAL
Intervention: Riboflavin supplementation (1.6 mg/day)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (MTHFR CC genotype)
Number of subjects: 80
Study: 35168622

Group type: EXPERIMENTAL
Intervention: Emergency Medicine Palliative Care Access (EMPallA) trial
Number of subjects: 504
Study: 34064328

Group type: EXPERIMENTAL
Intervention: Energy intake exceeding energy needs
Number of subjects: 7119

Group type: EXPERIMENTAL
Intervention: Increments over time in energy intake
Number of subjects: 7119

Group type: EXPERIMENTAL
Intervention: Energy deficit or reduction in energy intake over time
Number of subjects: 7119
Study: 32895271

Group type: EXPERIMENTAL
Intervention: Yoga programme for T2DM prevention (YOGA-DP)
Number of subjects: 64

Group type: COMPARATOR
Intervention: Enhanced standard care
Number of subjects: 64
Study: 35704398

Group type: EXPERIMENTAL
Intervention: Low-load blood flow restriction (LLBFR)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Low-load non-BFR (LL)
Number of subjects: 14

Group type: COMPARATOR
Intervention: Comparison of LLBFR and LL
Number of subjects: 14
Study: 35377948

Group type: EXPERIMENTAL
Intervention: Neoadjuvant durvalumab plus chemotherapy
Number of subjects: 57

Group type: COMPARATOR
Intervention: Placebo arm
Number of subjects: 57
Study: 33197078

Group type: EXPERIMENTAL
Intervention: SBT-020
Number of subjects: 0
Study: 34398258

Group type: EXPERIMENTAL
Intervention: Biosimilar (Elizaria)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Originator (Soliris)
Number of subjects: 32
Study: 32978017

Group type: EXPERIMENTAL
Intervention: Tooth-borne device (hyrax appliance)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Bone-borne device (computer-guided skeletal RME appliance)
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Both groups (Tooth-borne and Bone-borne)
Number of subjects: 36
Study: 33153310

Group type: EXPERIMENTAL
Intervention: Tear A (0.1% crosslinked hyaluronic acid, coenzyme Q10, and vitamin E)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Tear B (carmellose sodium)
Number of subjects: 60
Study: 34486676

Group type: EXPERIMENTAL
Intervention: Juice introduced <6 months
Number of subjects: 4067
Study: 33049146

Group type: EXPERIMENTAL
Intervention: Nonsense sentences from the newly developed corpus
Number of subjects: 40

Group type: COMPARATOR
Intervention: Original Basic English Lexicon (BEL) sentences
Number of subjects: 40
Study: 34269042

Group type: EXPERIMENTAL
Intervention: Air polishing with erythritol powder (EP)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Rubber cup method (control)
Number of subjects: 32
Study: 35483568

Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT) with exercise
Number of subjects: 78

Group type: EXPERIMENTAL
Intervention: Dry Needling (DN) with exercise
Number of subjects: 78

Group type: COMPARATOR
Intervention: Exercise alone (Control group)
Number of subjects: 78
Study: 33288437

Group type: EXPERIMENTAL
Intervention: Transdermal estradiol (100 μg/24 h) with intermittent micronized progesterone
Number of subjects: 101
Study: 35654480

Group type: EXPERIMENTAL
Intervention: Alfentanil (10 µg/kg before intubation) + sevoflurane anesthesia
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Tetanic stimulations (10, 30, and 60 milliamps)
Number of subjects: 30
Study: 32729619

Group type: EXPERIMENTAL
Intervention: gaboxadol 15 mg
Number of subjects: 41

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 41
Study: 33070582

Group type: EXPERIMENTAL
Intervention: Video Stylet (VS)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Fiberoptic Intubating Bronchoscope (FO)
Number of subjects: 50
Study: 32526195

Group type: EXPERIMENTAL
Intervention: Baloxavir (40 mg for patients <80 kg, 80 mg for patients ≥80 kg)
Number of subjects: 2184

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 2184

Group type: EXPERIMENTAL
Intervention: Oseltamivir (75 mg twice daily for 5 days)
Number of subjects: 2184

Group type: EXPERIMENTAL
Intervention: Baloxavir
Number of subjects: 2184

Group type: EXPERIMENTAL
Intervention: Oseltamivir
Number of subjects: 2184
Study: 35577646

Group type: EXPERIMENTAL
Intervention: Atezolizumab (two cycles prior to radical cystectomy)
Number of subjects: 95